- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04130893
Response of the Autonomic Nervous System to Auricular Stimulation of the Vagus Nerve (x) (AURIX)
While invasive vagal stimulation has proven its therapeutic effectiveness over the past 20 years, particularly in the treatment of epilepsy or depression, its implementation is hampered by the high cost, high technicality and sometimes significant side effects. Non-invasive vagal stimulation, most often electric, is a less expensive therapeutic alternative and easier to implement, although the level of evidence is lower than that of invasive stimulation.
Some so-called traditional therapies, such as acupuncture, also stimulate certain parts of the ear by mechanical means, most often by puncturing the ear or the concha. In these traditional therapies, more than one hundred stimulation points have been described, each precisely positioned according to an empirical topography.
However, electrical non-invasive stimulation recognizes only three areas of interest on the ear, which are the areas of sensitive innervation, namely the afferences of the vagus nerve in the concha, which is the only one used in practice, the large occipital nerve on the lobe and part of the helix, and the auriculotemporal nerve on the rest of the auricular flag.
In this study, we would like to explore the justification for the topographic precision, adopted by traditional therapies, for non-invasive vagal stimulation on the concha.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Main objective: to measure the physiological impact of two auricular stimuli on the same innervation territory but with opposite actions according to traditional therapies.
An identical physiological response on both stimulation points would be an argument against the topographical precision adopted by traditional therapies; conversely, a different physiological response would suggest the existence of a somatotopy nestled in the same innervation territory.
Secondary objectives:
- Determine, by sinus variability analysis, the intensity of the sympathetic and parasympathetic cardiac response of mechanical stimulation of the ear concha.
- Determine the existence of a blockage of the sympathetic reaction on cutaneous vasoconstriction after mechanical stimulation of the ear concha.
- Measure the relationship between sinus variability and paradoxical skin vasodilation after exposure to cold, as considered in the protocol.
To explore the justification for the topographical precision adopted by traditional therapies, we designed an experiment that consists of studying the autonomous, sympathetic and parasympathetic response to two stimuli performed over two different times.
The sympathetic stimulation will be done by immersing the right hand up to the wrist in a tub of cold water maintained at 5°C Mechanical parasympathetic stimulation will be performed on the ear in two different locations, by placing an adapted needle through an introducer to respect a standardized insertion depth.
The autonomous response will be measured by sinus variability, which responds to a double innervation, sympathetic and parasympathetic, and by the capillary skin response, which responds only to a sympathetic innervation.
The capillary skin response is measured by the amplitude and latency of the paradoxical vasodilation reflex following thermal stimulation, in this case the immersion of a limb's tip in cold water.
The study will consist of 3 sessions, as shown in the figure below. This is a prospective crossover study.
During the first session, the inclusion and non-inclusion criteria will be checked, then a water immersion test will be carried out to ensure the good tolerance of this test and then determine the basic values.
In the absence of acclimatization, the paradoxical vasodilation reflex is highly reproducible. During the second and third sessions, a mechanical stimulation will be done to the ear during the skin immersion test.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
PACA
-
Marseille, PACA, France, 13003
- Hôpital Européen Marseille
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy volunteers, male and female, aged 18 to 60 years
- BMI (Body mass index) <=30
- Not participating in another clinical study with an investigational product
Exclusion Criteria:
- Drug treatment for cardiological, neurological or anticoagulant purposes
- History of diabetes, known neuropathy, high blood pressure, heart rhythm disorders, syncope or palpitation
- Known cryoglobulinemia
- Subject with Raynaud's syndrome
- Intra-auricular device of the piercing type,
- Psychoactive substance use, excessive alcohol consumption (>2 units per day chronically or >6 units per day recreationally) and tobacco (>5 cigarettes per day)
- Subject unable to read French
- Subject covered by Articles L1121-5 to 1121-8 of the Public Health Code, namely:
- Pregnant, postpartum and breastfeeding women
- Persons deprived of their liberty by a judicial or administrative decision
- Persons undergoing psychiatric care under Articles L3112-1 and L3113-1 who are not covered by the provisions of Article L1121-8
- Minors
- Persons of full age who are subject to a legal protection measure or who are unable to express their consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: A stimulation of G13 then G15
The first session is similar between the two arms: Cold water hand immersion only At the Second session: Cold water hand immersion + G13 auricular stimulation At the Third session: Cold water hand immersion + G15 auricular stimulation
|
Study participant randomized into arm A will undergo a stimulation of point G13 at session N°2, then stimulation of point G15 at session N°3.
|
|
Experimental: B: stimulation of G15 then G13
The first session is similar between the two arms: Cold water hand immersion only At the Second session: Cold water hand immersion + G15 auricular stimulation At the Third session: Cold water hand immersion + G13 auricular stimulation
|
Study participant randomized into arm B will undergo a stimulation of point G15 at session N°2, then stimulation of point G13 at session N°3.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin temperature changes
Time Frame: 20 minutes
|
measured by thermocouples placed on the following fingers: thumb, middle finger and ear of the right hand.
The values and times of the minimum and maximum temperatures (latency and amplitude of (CIVD) Cold-Induced VasoDilatation waves) are measured
|
20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain reported by the participant
Time Frame: 20 minutes
|
Measured by visual analogue scale; this scale ranges from 0 to 10; 0 being no pain, 10 being excruciating pain.
|
20 minutes
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sinus variability
Time Frame: 20 minutes
|
measured by cardiofrequency meter(ACTIWAVE ®)
|
20 minutes
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Emmanuel SAGUI, MD, Hôpital Européen Marseille
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 18-36
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vasoconstriction Disorder of Extremities
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Not yet recruitingStage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Soft Tissue Sarcoma of the Trunk and Extremities | Recurrent Soft Tissue Sarcoma of the Trunk and Extremities | Resectable Soft Tissue Sarcoma of the Trunk...
-
Maastricht University Medical CenterNot yet recruitingTypes of C-arm Procedures Included | Low Complex (Lower & Upper Extremities) | High Complex (Lower Extremities & Spinal Cord)
-
University of WashingtonExelixisTerminatedStage I Soft Tissue Sarcoma of the Trunk and Extremities | Stage II Soft Tissue Sarcoma of the Trunk and Extremities | Sarcoma of the Extremity | Stage IA Soft Tissue Sarcoma of the Trunk and Extremities | Stage IB Soft Tissue Sarcoma of the Trunk and ExtremitiesUnited States
-
M.D. Anderson Cancer CenterRecruitingStage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8United States
-
Italian Sarcoma GroupFondazione IRCCS Istituto Nazionale dei Tumori, MilanoNot yet recruitingSoft Tissue Sarcoma of the Trunk and Extremities
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Resectable... and other conditionsUnited States
-
Versono Medical LtdCompletedChronic Total Occlusion of Arteries of the ExtremitiesDominican Republic
-
University of PatrasUnknownChronic Total Occlusion of Artery of the ExtremitiesGreece, Italy, United Kingdom
-
ReFlow Medical, Inc.CompletedChronic Total Occlusion of Artery of the ExtremitiesUnited States
-
SoundBite Medical Solutions, Inc.ethica Clinical Research Inc.; Prairie Vascular Research Inc.CompletedChronic Total Occlusion of Arteries of the ExtremitiesUnited States, Canada
Clinical Trials on stimulation of G13 then G15
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAxial SpondyloarthritisFrance
-
Dr. med. Carlo CeredaUniversity Hospital Inselspital, Berne; CLINICA HILDEBRAND CENTRO DI RIABILITAZIONE... and other collaboratorsUnknownIschemic Stroke | First Ever Clinical Stroke | Subacute Phase | Persistent Hemiparesis of Upper ExtremitySwitzerland
-
Virginia Commonwealth UniversityCompleted
-
Centre Hospitalier Universitaire de NiceCompletedAlzheimer's Disease | MCIFrance
-
Elahi, Dariush, PhDMassachusetts General Hospital; National Institute on Aging (NIA); ICON plcUnknownInsulin ResistanceUnited States
-
University of RochesterEndo PharmaceuticalsTerminated
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedDiabetes Mellitus, Type 2United States
-
University Hospital, Strasbourg, FranceRecruitingElectronic CigaretteFrance
-
MacDonald, Kai, M.D.CompletedAnxiety | BehaviorUnited States
-
Medical University of South CarolinaTakeda Pharmaceuticals North America, Inc.CompletedDiabetesUnited States